TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
9.69
+0.02 (0.21%)
Sep 5, 2025, 1:30 PM CST

TPEX:4157 Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Cash & Equivalents
37.4874.14374.66243.11364.9360.85
Upgrade
Short-Term Investments
809.56751.28598.2591.11495.38197.22
Upgrade
Trading Asset Securities
66.91194.465.1464.3964.0972.7
Upgrade
Cash & Short-Term Investments
913.951,0201,038898.6924.4330.78
Upgrade
Cash Growth
-17.12%-1.75%15.51%-2.79%179.46%-48.12%
Upgrade
Accounts Receivable
11.197.338.9818.41278.287.31
Upgrade
Other Receivables
36.489.0724.885.32.6128.64
Upgrade
Receivables
47.6716.433.8723.71280.8935.95
Upgrade
Inventory
44.6742.7134.1515.3517.8814.65
Upgrade
Other Current Assets
9.527.164.3711.578.8410.22
Upgrade
Total Current Assets
1,0161,0861,110949.241,232391.6
Upgrade
Property, Plant & Equipment
52.6667.4790.6156.680.4342.47
Upgrade
Long-Term Investments
2.732.459.7123.9853.985.86
Upgrade
Other Intangible Assets
12.5912.0512.990.230.160.29
Upgrade
Other Long-Term Assets
5.496.226.1616.9626.3136.24
Upgrade
Total Assets
1,0891,1741,2301,0471,393556.45
Upgrade
Short-Term Debt
35--3--
Upgrade
Current Portion of Leases
16.516.3315.9818.3417.9917.12
Upgrade
Current Income Taxes Payable
-0.11-3.0727.86-
Upgrade
Current Unearned Revenue
0.170.150.150.150.1844.41
Upgrade
Other Current Liabilities
27.6129.531.7626.7643.8533.37
Upgrade
Total Current Liabilities
79.2846.0847.8951.3289.8894.91
Upgrade
Long-Term Leases
34.0942.3958.7117.1335.47-
Upgrade
Long-Term Unearned Revenue
0.140.180.330.480.620.79
Upgrade
Total Liabilities
116.7391.96110.9476.98139.11114.26
Upgrade
Common Stock
20.9420.9420.9420.9120.9120.91
Upgrade
Additional Paid-In Capital
456.43466.3444.61450.26455.25675.14
Upgrade
Retained Earnings
495.06640.6678.68542.05778.3-300.21
Upgrade
Comprehensive Income & Other
0.11-45.51-25.34-43.2-0.7746.34
Upgrade
Shareholders' Equity
972.531,0821,119970.031,254442.18
Upgrade
Total Liabilities & Equity
1,0891,1741,2301,0471,393556.45
Upgrade
Total Debt
85.5958.7174.6938.4753.4617.12
Upgrade
Net Cash (Debt)
828.36961.11963.3860.13870.94313.66
Upgrade
Net Cash Growth
-20.04%-0.23%12.00%-1.24%177.67%-45.10%
Upgrade
Net Cash Per Share
1.151.341.341.201.210.44
Upgrade
Filing Date Shares Outstanding
722.9717.84717.84716.84716.84716.84
Upgrade
Total Common Shares Outstanding
722.9717.84717.84716.84716.84716.84
Upgrade
Working Capital
936.521,0401,062897.921,142296.69
Upgrade
Book Value Per Share
1.351.511.561.351.750.62
Upgrade
Tangible Book Value
959.941,0701,106969.81,254441.89
Upgrade
Tangible Book Value Per Share
1.331.491.541.351.750.62
Upgrade
Machinery
-144.93144.38143.76140.92148.2
Upgrade
Leasehold Improvements
-60.7960.6660.7160.6758.11
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.